Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pfizer Invites Investors, Analysts And Media To Join Conference Calls Discussing Pfizer's Proposed Acquisition of Hospira

PFE

Pfizer will hold an analyst and investor call to discuss its proposed acquisition of Hospira at 9:00 AM EST (2:00 PM GMT) today, February 5, 2015.

Pfizer will also hold a media call at 10:15 AM EST (3:15 PM GMT) today, February 5, 2015.

The information to access the calls can be found below.

INVESTOR / ANALYST CALL

February 5, 2015
9.00 AM EST / 2.00 PM GMT

Participant Dial in:

Participant Toll-Free Dial-In Number: (877) 409-7641
Participant International Dial-In Number: (631) 485-4301
Password: Analyst Call

Webcast link:
http://www.visualwebcaster.com/event.asp?id=101579

MEDIA CALL

February 5, 2015
10:15 AM EDT / 3:15 PM GMT

Participant Dial in:

Participant Toll-Free Dial-In Number: (877) 884-4775
Participant International Dial-In Number: (631) 485-4564
Password: Media Call

Webcast link:
http://www.visualwebcaster.com/event.asp?id=101584

Pfizer Inc.
Media Relations:
Joan Campion, 212-733-2798
Andrew Topen, 212-733-1338
or
Investor Relations:
Chuck Triano, 212-733-3901
or
Hospira, Inc.
Media Relations:
Stacey Eisen, 224-212-2357
or
Investor Relations:
Karen King, 224-212-2711